How Cutiss managed to scale-up production
The Swiss start-up Cutiss AG from Zurich has found a way to bioengineer customised skin that mimics skin and minimises scaring. It is produced manually in cleanroom to perform clinical studies. But to ensure scalability, while maintaining safety and efficacy of denovoSkin, Cutiss AG is having to explore new production avenues.
For two years, the company has been working with Zühlke to develop the concept for an automated closed system. In our whitepaper, the various decisions made during the ongoing development process are explained in greater detail. The article is also intended to show how a start-up vision becomes reality and how the solution evolves to fulfil the needs.
On the path to defining the system architecture, four main questions were asked about the solution:
- Should it be fully automated?
- Fully connected?
- Fully closed?
- Fully mechanised?
